Tel.: +49 6221 868023
Fax: +49 6221 8680255

murine MAb against BpcA of Borrelia parkeri, Clone Bp-3/32.2

Tick-borne relapsing fever (TBRF) in North America is caused by the spirochete species Borrelia hermsii, Borrelia parkeri and Borrelia turicatae, which are transmitted to humans through the bite of the respective infected Ornithodoros tick vector. The pathogen employs multiple strategies, including the acquisition of complement regulators and antigenic variation, to escape innate and adaptive immune responses and to persist in the blood. The outer surface lipoprotein BpcA binds the complement regulators factor H and FH-related protein 1 and, simultaneously, the host plasminogen/plasmin and may aid in the spirochete’s dissemination and invasion.

The monoclonal antibody ADG0173L (Bp-3/32-2) is a murine monoclonal antibody recognizing BpcA of Borrelia parkeri strain RML. Mice were immunized with rec. BpcA. The antibody has been purified from cell culture supernatant using Protein G affinity chromatography.

Vial containing 1 mg purified antibody in PBS pH 7.4. The concentration is given on the vial label. Spin the vial briefly before opening.

Storage and Stability
Store the antibody at 2°-8°C. For long-term storage the antibody should be aliquoted and stored at –20°C or colder. It is recommended to avoid freeze-thaw cycles.

The antibody can be used as capture antibody in ELISAs. An antibody concentration of 1-10 µg/ml is recommended.
The antibody can be used for immune-cytochemistry on paraformaldehyde fixed spirochetes.
The antibody is suitable for Western blot analysis, detecting native and recombinant BpcA following SDS-PAGE under reducing conditions. A primary antibody concentration of 1-10 µg/mL is recommended.
Surface exposition of BpcA. Proteinase K and trypsin treatment affects surface expression of native BpcA. B. parkeri cells were incubated with the indicated concentrations of proteinase K and trypsin, lysed,  immunoblotted, and probed with anti-BpcA mAb Bp-3/32.2.

Research use only

Type: Antibody

Product Availability: Worldwide

Manufacturer: ImmBioMed GmbH & Co KG, Germany

For more information please click .pdf icon below.

murine MAb against BpcA of Borrelia parkeri, Clone Bp-3/32.2

Cat.No. ADG0173L (research box)
Artikelnr.: 938331

Einheit: 1,0 mg

Code: ADG0173L

Hersteller: ImmBioMed GmbH & Co. KG - from the research box


  1. Binding of human urokinase type plasminogen activator and plasminogen to Borrelia species. Klempner et al. J. Infect. Dis. 1996; 174(1):97-104
  2. Molecular characterization of the interaction of Borrelia parkeri and Borrelia turicatae with human complement regulators. Schott et al. Infect. Immun. 2010; 78(5):2199-2208
  3. Immune evasion strategies of relapsing fever spirochetes. Rötterding and Kraiczy. Front. Immunol. 2020; 11:1560

Diese Webseite verwendet Cookies. Durch die Nutzung der Webseite stimmen Sie der Verwendung von Cookies zu. Datenschutzerklärung X